We are live on ! Find out more
SGAM

Smith Group Asset Management Portfolio holdings

AUM $2.46B
1-Year Est. Return 57.16%
This Fund
S&P 500
This Quarter Est. Return
+9.9%
1 Year Est. Return
+57.16%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.89B
AUM Growth
+$159M
Cap. Flow
+$27.9M
Cap. Flow %
1.48%
Top 10 Hldgs %
34.09%
Holding
355
New
45
Increased
117
Reduced
138
Closed
28

Top Buys

Rank Stock Value
1
COF icon
Capital One
COF
+$36.2M
2
WST icon
West Pharmaceutical
WST
+$24.3M
3
NVST icon
Envista
NVST
+$23.9M
4
JPM icon
JPMorgan Chase
JPM
+$22.1M
5
ETN icon
Eaton
ETN
+$15.3M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$23.5M
2
ALL icon
Allstate
ALL
+$22.6M
3
CDNS icon
Cadence Design Systems
CDNS
+$21.3M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$20.7M
5
ZBRA icon
Zebra Technologies
ZBRA
+$15.7M

Sector Composition

Rank Sector Weight
1 Technology 30.41%
2 Consumer Discretionary 14.8%
3 Healthcare 14.63%
4 Financials 11.82%
5 Industrials 10.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FHI icon
201
Federated Hermes
FHI
$4.71B
$21K ﹤0.01%
660
-17,700
-96% -$520K
FLNA
202
Filana Therapeutics
FLNA
$48.2M
$21K ﹤0.01%
+460
New +$18.1K
SNBR
203
DELISTED
Sleep Number
SNBR
$21K ﹤0.01%
145
-3,975
-96% -$477K
BERY
204
DELISTED
Berry Global Group, Inc.
BERY
$21K ﹤0.01%
370
+43
+13% +$2.23K
ETRN
205
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
$21K ﹤0.01%
2,631
+340
+15% +$2.59K
AMRX icon
206
Amneal Pharmaceuticals
AMRX
$5.71B
$20K ﹤0.01%
2,990
-69,640
-96% -$386K
BKR icon
207
Baker Hughes
BKR
$63.6B
$20K ﹤0.01%
904
+120
+15% +$2.73K
DINO icon
208
HF Sinclair
DINO
$15.2B
$20K ﹤0.01%
558
+54
+11% +$1.8K
SYNH
209
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$20K ﹤0.01%
270
-7,470
-97% -$563K
AXP icon
210
American Express
AXP
$229B
$19K ﹤0.01%
137
+23
+20% +$3.04K
EC icon
211
Ecopetrol
EC
$35.1B
$19K ﹤0.01%
1,480
+190
+15% +$2.46K
EXTR icon
212
Extreme Networks
EXTR
$3.09B
$19K ﹤0.01%
+2,130
New +$18.6K
GS icon
213
Goldman Sachs
GS
$301B
$19K ﹤0.01%
57
+10
+21% +$3.11K
NDAQ icon
214
Nasdaq
NDAQ
$53.4B
$19K ﹤0.01%
378
+63
+20% +$2.99K
PRSP
215
DELISTED
Perspecta Inc. Common Stock
PRSP
$19K ﹤0.01%
670
-17,900
-96% -$504K
BOOT icon
216
Boot Barn
BOOT
$5.11B
$18K ﹤0.01%
+290
New +$17K
DD icon
217
DuPont de Nemours
DD
$19.1B
$18K ﹤0.01%
190
+30
+19% +$2.88K
DFS
218
DELISTED
Discover Financial Services
DFS
$18K ﹤0.01%
186
+27
+17% +$2.55K
EQT icon
219
EQT Corp
EQT
$33.8B
$18K ﹤0.01%
980
+90
+10% +$1.57K
FAF icon
220
First American
FAF
$7.37B
$18K ﹤0.01%
320
+50
+19% +$2.73K
HUN icon
221
Huntsman Corp
HUN
$1.82B
$18K ﹤0.01%
621
+70
+13% +$1.96K
JACK icon
222
Jack in the Box
JACK
$340M
$18K ﹤0.01%
160
-4,280
-96% -$435K
SUPN icon
223
Supernus Pharmaceuticals
SUPN
$2.74B
$18K ﹤0.01%
700
-31,368
-98% -$877K
KGC icon
224
Kinross Gold
KGC
$32.5B
$17K ﹤0.01%
2,504
+290
+13% +$2.02K
ENB icon
225
Enbridge
ENB
$112B
$16K ﹤0.01%
453
+50
+12% +$1.76K
7 8
9
10 11

Similar funds

M
Mirova Paris, France $2.46B AUM 11.42% 1-Year Est. Return
GWM
Greenwich Wealth Management Greenwich, Connecticut $2.45B AUM 39.53% 1-Year Est. Return
QT
Quantbot Technologies New York $2.44B AUM 17.13% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
TW
Trajan Wealth Scottsdale, Arizona $2.48B AUM 17.44% 1-Year Est. Return
KFA
Krane Funds Advisors New York $2.44B AUM 12.99% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $2.48B AUM 72.25% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Smith Group Asset Management's Q1 2021 Portfolio in Review

As of Q1 2021, Smith Group Asset Management held 355 positions worth $1.89B, up 9.2% from $1.73B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Smith Group Asset Management's Q1 2021 filing shows 45 new, 117 increased, 138 reduced and 28 closed positions. Its largest new stake was West Pharmaceutical: 84,965 shares worth $24M. The largest sale was Apple, an estimated $23.5M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Smith Group Asset Management's largest Q1 2021 buy was West Pharmaceutical: 84,965 shares worth $24M.
  • Smith Group Asset Management added most to Capital One in Q1 2021, an estimated $36.2M increase.
  • Smith Group Asset Management's biggest Q1 2021 reduction was Apple, cutting an estimated $23.5M.
  • Smith Group Asset Management fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q1 2021, selling an estimated $20.7M.
  • Smith Group Asset Management's ten largest holdings make up 34% of its $1.89B portfolio in Q1 2021.
  • Smith Group Asset Management opened 45 new positions and closed 28 in Q1 2021.
  • Smith Group Asset Management's portfolio value rose 9.2% quarter-over-quarter to $1.89B.

Based on Smith Group Asset Management's 13F filing for Q1 2021, filed 7 May 2021.